Fairholme's Q4 portfolio has been filed. New or increased positions include C, BNI, CIT, CMCSK, RF, CMCSA, MI, BRKa, ACF, HUM, WLP, HTZ, SPR, FUR, RRR, JOE, and LUK.
Tonight's Of Mutual Interest interview focuses on a leading large cap value fund -- The Fairholme Fund (FAIRX). NBR's Paul Kangas asks Fairholme's Bruce Berkowitz about the fund's performance. Berkowitx also talks about some sectors he likes.
This short article updates readers on the latest moves by Bruce Berkowitz's Fairholme Fund. I didn't realize Leucadia has been removed from the fund's holdings until reading this article.
Andrew Barry of Barron's concludes, "Leucadia now looks like an attractive play on its depressed investments and on the ability of Cumming and Steinberg to find new opportunities. Unless the pair has indeed taken "stupid pills," investors could do well taking a ride with them." This article will likely draw the attention of most value investors this week.
Buy low, sell high. It's obviously good advice. In practice, it's not as easy as it sounds. How do you know tomorrow the price will not drop another 10% or 30% for that matter? If you bought today with all the cash at hand and it drops another 50% tomorrow, no amount of self-kicking would relief the pain inflicted.
It is fascinating to see how Leucadia is boosting its stake in Americredit. One just has to conclude that Leucadia believes that some of the stocks impacted by the credit sector issues are now beaten down enough to start preying on them
Recent comments
2 days 1 hour ago
2 days 3 hours ago
2 days 19 hours ago
4 days 5 hours ago
6 days 3 hours ago
6 days 8 hours ago
1 week 2 days ago
4 weeks 2 days ago
5 weeks 3 days ago
7 weeks 6 days ago